4//SEC Filing
Beardsley Robert A 4
Accession 0000899243-22-030911
CIK 0001563577other
Filed
Sep 12, 8:00 PM ET
Accepted
Sep 13, 4:10 PM ET
Size
6.8 KB
Accession
0000899243-22-030911
Insider Transaction Report
Form 4
Beardsley Robert A
Chief Operating Officer
Transactions
- Exercise/Conversion
Stock Option
2022-09-12−10,000→ 85,651 totalExercise: $1.07Exp: 2022-11-25→ Common Stock (10,000 underlying) - Exercise/Conversion
Common Stock
2022-09-12$1.07/sh+10,000$10,700→ 98,191 total
Footnotes (1)
- [F1]The option has fully vested and is currently exercisable.
Documents
Issuer
Galera Therapeutics, Inc.
CIK 0001563577
Entity typeother
Related Parties
1- filerCIK 0001310845
Filing Metadata
- Form type
- 4
- Filed
- Sep 12, 8:00 PM ET
- Accepted
- Sep 13, 4:10 PM ET
- Size
- 6.8 KB